Boston, MA – May 14, 2015 — BioDirection, Inc. a developer of groundbreaking point-of care technology for the objective diagnosis, prognosis and monitoring of concussions and other traumatic brain injuries (TBI) was named the 2015 “Rising Star” from the Small Business Association of New England (SBANE) Innovation Awards. Its Tbit™ test, currently under development, will objectively diagnose concussions and other brain injuries from a single drop of blood in less than 90 seconds.
The Rising Star Award recognizes companies that are in early stages of development but have clearly demonstrated the validity of their business and the potential for significant growth. Approximately 70 independent judges evaluated more than 175 nominated companies. Past SBANE award winners include Staples, Ben and Jerry’s, Genzyme, Nantucket Nectars and KRONOS.
“BioDirection is honored to receive this prestigious recognition from SBANE. The SBANE award process is a rigorous, multi-phased and well-regarded one, and we are proud to join SBANE’s ‘Circle of Excellence’”, said Eric Goorno, President & CEO of BioDirection. “In our case, the Rising Star Award recognizes our company’s innovative approach in helping to address the enormous global medical issues surrounding traumatic brain injury.”
A TBI occurs every 15 seconds in the U.S. alone:
- Resulting in over 10 million concussions a year
- Driving over 4 million people to go to the ER
- Creating $76 billion each year in direct and indirect costs
- Resulting in over 4 million head CT scans annually